News Snapshot:
ADELAIDE, Australia--(BUSINESS WIRE)--Jan 19, 2022-- BiomeBank today announces Mr Chris Hall as the new Chair for the clinical stage biotechnology company, having recently served as Chief Investment Officer of Ellerston Capital. Prior to this, Mr Hall served as Managing Director of Blackrock Asset Management (North-Asia Ltd). The appointment is effective as of 17 January 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220119005391/en/ New BiomeBank Chair, Mr Chris Hall. (Photo: Business Wire) Mr Hall succeeds Dr Stephen Rodda, who recently retired having served as the BiomeBank Chair since 2019. BiomeBank Chief Executive Officer, Mr Thomas Mitchell said:...